Table 1. Risk management procedures over the 12 months from genetic testing according to age (⩾50 or <50 years) and carrier status (percentage of women).

	Carrier (<50)	Carrier (⩾50)	Noncarrier (<50)	Noncarrier (⩾50)
Mammogram	75	100	24	41
CBE	65	100	26	12
Tamoxifen	2	20	1	6
BRMx	28	0	0	0
Ov US	61	40	5	12
BROx	32	40	2	2
Breast biopsy	3	20	4	5
Ovarian biopsy	7	0	0	2
BrSE	96	100	95	88